Latest Articles

Publication Date
Princess Kate health: Doctor warns abdominal surgery can be ‘high risk’ - Express

Princess Kate health: Doctor warns abdominal surgery can be ‘high risk’ Express

Published: Jan. 17, 2024, 8 a.m.
Woman's Hour's Emma Barnett pleads for more focus on women’s health - Express

Woman's Hour's Emma Barnett pleads for more focus on women’s health Express

Published: Jan. 17, 2024, 8 a.m.
A Prospective Study to Evaluate the Role of Combined Diagnostic Laparoscopy and Hysteroscopy in the Management of Female Infertility - Cureus

A Prospective Study to Evaluate the Role of Combined Diagnostic Laparoscopy and Hysteroscopy in the Management of Female Infertility Cureus

Published: Jan. 12, 2024, 8 a.m.
Endometrial biopsy performed before the first in vitro fertilization does not impact the early pregnancy rate - Nature.com

Endometrial biopsy performed before the first in vitro fertilization does not impact the early pregnancy rate Nature.com

Published: Jan. 11, 2024, 8 a.m.
Menstrual cramps: Why aren’t there better options than just popping painkillers? - The Indian Express

Menstrual cramps: Why aren’t there better options than just popping painkillers? The Indian Express

Published: Jan. 11, 2024, 8 a.m.
New drug offers promising breakthrough for endometriosis patients - The Telegraph

New drug offers promising breakthrough for endometriosis patients The Telegraph

Published: Jan. 9, 2024, 8 a.m.
When will women get real reproductive health care in America? - The Hill

When will women get real reproductive health care in America? The Hill

Published: Jan. 9, 2024, 8 a.m.
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis - Nature.com

SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis Nature.com

Published: Jan. 8, 2024, 8 a.m.
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million - Business Wire

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million Business Wire

Published: Jan. 8, 2024, 8 a.m.
NHS: GP says private care can help cut waiting lists - BBC.com

NHS: GP says private care can help cut waiting lists BBC.com

Published: Jan. 8, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!